- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有556家主力机构披露2025-06-30报告期持股数据，持仓量总计1.68亿股，占流通A股41.96%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了38%的股票
技术面评分前10的股票
近期的平均成本为102.23元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为102.23元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"102.23","date":1763365979,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.11.18","stock":"0.43","trade":"-0.92","ind":"-0.92"},{"date":"2025.11.17","stock":"-2.29","trade":"-2.18","ind":"-0.11"},{"date":"2025.11.14","stock":"0.09","trade":"0.63","ind":"-1.93"},{"date":"2025.11.13","stock":"0.99","trade":"1.09","ind":"1.78"},{"date":"2025.11.12","stock":"-0.20","trade":"0.87","ind":"-0.36"},{"date":"2025.11.11","stock":"-1.34","trade":"0.43","ind":"-1.03"},{"date":"2025.11.10","stock":"0.54","trade":"1.72","ind":"0.18"},{"date":"2025.11.07","stock":"-1.44","trade":"-0.48","ind":"-0.36"},{"date":"2025.11.06","stock":"0.63","trade":"-0.33","ind":"1.73"},{"date":"2025.11.05","stock":"-1.29","trade":"-0.81","ind":"0.37"},{"date":"2025.11.04","stock":"-1.36","trade":"-0.81","ind":"-1.71"},{"date":"2025.11.03","stock":"-3.60","trade":"0.04","ind":"0.19"},{"date":"2025.10.31","stock":"-2.55","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-2.00","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"0.90","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"0.31","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"-1.44","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"0.16","trade":"0.39","ind":"2.02"},{"date":"2025.10.23","stock":"-1.23","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"-0.97","trade":"-0.28","ind":"-0.62"},{"date":"2025.10.21","stock":"-0.69","trade":"1.45","ind":"2.06"}]
长春高新,深证成指,生物制品指数
压力支撑
该股压力位为102.12元，支撑位为101.64元。
[{"text":"\u538b\u529b\u4f4d","value":"102.12","date":1763395200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"101.64","date":1763395200,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.3资金面打败了10%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月18日 17:59
| 机构今日流向(万元) | -2507.22 | 机构5日流向(万元) | -6456.55 |
| 机构10日流向(万元) | -11329.00 | 机构20日流向(万元) | -14442.68 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1484.33万股，其中基金净减仓112家，主力净增仓158家，请投资者中长期谨慎为宜。
截止2025-06-30，共556家主力机构（基金553家，一般法人3家），持仓量总计16766.25万股，占流通A股41.96%
其中，基金持仓与2024-12-31相比：
增仓：63家 ，增持 265.40万股
减仓：175家 ，减持 786.86万股
新出现在主力名单中：281家 ，持有2487.73万股
从主力名单中消失：123家 ，原持有574.16万股
其中，基金持仓与2024-12-31相比：
增仓：63家 ，增持 265.40万股
减仓：175家 ，减持 786.86万股
新出现在主力名单中：281家 ，持有2487.73万股
从主力名单中消失：123家 ，原持有574.16万股
消息面诊股
诊断结果：5.5消息面打败了5%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 长春高新：11月17日持仓该股ETF资金净流入29
2025-11-18 - “东北药茅”长春高新拟赴港上市，证监会就募资用途等
2025-11-17 - 创新药出海：被机构重仓的13家公司
2025-11-17 - 长春高新：11月14日持仓该股ETF资金净流入88
2025-11-17 - 长春高新：11月14日获融资买入1.36亿元
2025-11-17 - 长春高新：金赛药业口服生长激素新药国内尚无同类产品
2025-11-14 - 长春高新：公司股份回购期限届满
2025-11-14 - 长春高新拟港股上市 中国证监会要求补充说明募集资金
2025-11-14 - 长春高新：子公司GS3-007a干混悬剂境内生产药
2025-11-14 - 行业周报|生物制品指数涨4.81%, 跑赢上证指数
2025-11-14
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
| 一般消息 | 高管变动 | 个人工作原因 | 2025-08-14 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派26元(含税) | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.8行业面打败了76%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.11.18","price":"-0.92","value":"-0.92"},{"date":"2025.11.17","price":"-0.11","value":"-2.18"},{"date":"2025.11.14","price":"-1.93","value":"0.63"},{"date":"2025.11.13","price":"1.78","value":"1.09"},{"date":"2025.11.12","price":"-0.36","value":"0.87"},{"date":"2025.11.11","price":"-1.03","value":"0.43"},{"date":"2025.11.10","price":"0.18","value":"1.72"},{"date":"2025.11.07","price":"-0.36","value":"-0.48"},{"date":"2025.11.06","price":"1.73","value":"-0.33"},{"date":"2025.11.05","price":"0.37","value":"-0.81"},{"date":"2025.11.04","price":"-1.71","value":"-0.81"},{"date":"2025.11.03","price":"0.19","value":"0.04"},{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.62","value":"-0.28"},{"date":"2025.10.21","price":"2.06","value":"1.45"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 金迪克 | 61.45% | 7.33% | 5.5分 |
| 2 | 博晖创新 | 38.42% | 31.50% | 5.8分 |
| 3 | 万泽股份 | 31.67% | -6.60% | 6.5分 |
| 4 | - | 15.06% | 1.09% | 分 |
| 5 | 华兰疫苗 | 15.04% | 1.21% | 6.0分 |
| 6 | *ST双成 | 11.32% | 0.00% | 6.1分 |
| 8 | 康华生物 | 10.57% | -0.78% | 5.8分 |
| 10 | 沃森生物 | 6.99% | -3.35% | 4.8分 |
| 12 | 优宁维 | 6.07% | 1.19% | 6.5分 |
| 14 | 昊帆生物 | 5.15% | -0.81% | 6.3分 |
| 16 | - | 4.97% | -6.95% | 分 |
| 18 | 智飞生物 | 3.90% | -3.35% | 4.7分 |
| 20 | 赛伦生物 | 2.66% | -1.34% | 6.6分 |
| 22 | 诺诚健华 | 2.64% | -1.65% | 6.0分 |
| 24 | 百克生物 | 2.38% | -1.90% | 6.1分 |
| 26 | 艾迪药业 | 1.90% | -0.62% | 5.7分 |
| 28 | 安科生物 | 0.87% | -6.54% | 5.0分 |
| 30 | 上海莱士 | 0.45% | -3.03% | 5.5分 |
| 32 | 派林生物 | -0.31% | 0.00% | 6.3分 |
| 34 | - | -1.08% | 0.79% | 分 |
| 36 | 欧林生物 | -1.24% | -2.86% | 6.8分 |
| 38 | 智翔金泰 | -2.07% | -2.61% | 4.8分 |
| 40 | 康希诺 | -3.25% | -5.36% | 5.1分 |
| 42 | 凯因科技 | -3.72% | -3.45% | 5.1分 |
| 44 | 天坛生物 | -4.30% | -2.04% | 5.3分 |
| 46 | 迈威生物 | -6.49% | 0.52% | 5.1分 |
| 48 | 康弘药业 | -7.19% | -0.76% | 6.4分 |
| 50 | 科兴制药 | -7.89% | -7.29% | 5.9分 |
| 52 | 康辰药业 | -11.49% | -2.21% | 5.4分 |
| 54 | 禾元生物 | - | -7.03% | 3.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 17/72 ， 14/72。
[{"date":"2025-09-30","value":"5.06","vol":"-9.78"},{"date":"2025-06-30","value":"4.29","vol":"-0.61"},{"date":"2025-03-31","value":"2.03","vol":"0.46"},{"date":"2024-12-31","value":"11.46","vol":"-0.68"},{"date":"2024-09-30","value":"12.38","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.06 | 4.29 | 2.03 | 11.46 | 12.38 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"83.95","vol":"67.61"},{"date":"2025-06-30","value":"83.35","vol":"68.28"},{"date":"2025-03-31","value":"88.22","vol":"68.43"},{"date":"2024-12-31","value":"85.72","vol":"69.85"},{"date":"2024-09-30","value":"85.60","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
83.95 | 83.35 | 88.22 | 85.72 | 85.60 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 38/72 ， 43/72。
[{"date":"2025-09-30","value":"-5.60","vol":"45.25"},{"date":"2025-06-30","value":"-0.54","vol":"6902.04"},{"date":"2025-03-31","value":"-5.66","vol":"6125.27"},{"date":"2024-12-31","value":"-7.55","vol":"47.35"},{"date":"2024-09-30","value":"-2.75","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.60 | -0.54 | -5.66 | -7.55 | -2.75 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-58.23","vol":"44.80"},{"date":"2025-06-30","value":"-42.85","vol":"5.44"},{"date":"2025-03-31","value":"-44.95","vol":"-8.46"},{"date":"2024-12-31","value":"-43.01","vol":"-9.81"},{"date":"2024-09-30","value":"-22.80","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-58.23 | -42.85 | -44.95 | -43.01 | -22.80 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，两项指标的行业排名分别为 10/72 ， 46/72。
[{"date":"2025-09-30","value":"0.31","vol":"0.22"},{"date":"2025-06-30","value":"0.21","vol":"0.14"},{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.44","vol":"0.29"},{"date":"2024-09-30","value":"0.34","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.21 | 0.10 | 0.44 | 0.34 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.29","vol":"0.92"},{"date":"2025-06-30","value":"0.23","vol":"0.56"},{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"0.40","vol":"1.17"},{"date":"2024-09-30","value":"0.31","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.29 | 0.23 | 0.07 | 0.40 | 0.31 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-15.58","vol":"1.84"},{"date":"2025-06-30","value":"18.03","vol":"-1377.61"},{"date":"2025-03-31","value":"19.05","vol":"-46.99"},{"date":"2024-12-31","value":"0.27","vol":"-11.33"},{"date":"2024-09-30","value":"29.83","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -15.58 | 18.03 | 19.05 | 0.27 | 29.83 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.46","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.27","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.46 | - | 3.27 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 32/72 ， 23/72。
[{"date":"2025-09-30","value":"3.85","vol":"6.00"},{"date":"2025-06-30","value":"3.50","vol":"6.64"},{"date":"2025-03-31","value":"4.32","vol":"7.75"},{"date":"2024-12-31","value":"4.76","vol":"6.72"},{"date":"2024-09-30","value":"4.89","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.85 | 3.50 | 4.32 | 4.76 | 4.89 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.12","vol":"4.84"},{"date":"2025-06-30","value":"2.23","vol":"5.30"},{"date":"2025-03-31","value":"2.67","vol":"6.35"},{"date":"2024-12-31","value":"3.07","vol":"5.40"},{"date":"2024-09-30","value":"3.26","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.12 | 2.23 | 2.67 | 3.07 | 3.26 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 30/72 ， 30/72。
[{"date":"2025-09-30","value":"17.55","vol":"28.18"},{"date":"2025-06-30","value":"18.75","vol":"26.73"},{"date":"2025-03-31","value":"16.20","vol":"26.03"},{"date":"2024-12-31","value":"15.94","vol":"25.81"},{"date":"2024-09-30","value":"16.28","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.55 | 18.75 | 16.20 | 15.94 | 16.28 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.24","vol":"0.58"},{"date":"2025-06-30","value":"0.26","vol":"1.11"},{"date":"2025-03-31","value":"0.22","vol":"0.78"},{"date":"2024-12-31","value":"0.22","vol":"0.87"},{"date":"2024-09-30","value":"0.22","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.24 | 0.26 | 0.22 | 0.22 | 0.22 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中国银河 | 2025-10-31 | 买入 | 买入 |
| 中泰证券 | 2025-09-28 | 买入 | 买入 |
| 天风证券 | 2025-09-24 | 买入 | |
| 华鑫证券 | 2025-09-24 | 买入 | |
| 财通证券 | 2025-09-11 | 增持 | |
| 国泰海通证券 | 2025-09-09 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"37.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"41.41","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"45.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.83","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"23.71","blueLineValue":"5.81","type":"YC"}]